EZH2 and prostate neoplasm: In contrast, both benign prostates and prostate tumors in the PtenLoxP/LoxP, PB4-Cre males expressed significantly higher levels of Ezh2 than the prostates of the WT males (GSE76822, GSE56469, and GSE98493) [7,44,45] (Figure 4d).